|
|
| | SARS-CoV-2 Spike Glycoprotein Polyclonal Antibody Basic information |
| | SARS-CoV-2 Spike Glycoprotein Polyclonal Antibody Chemical Properties |
| | SARS-CoV-2 Spike Glycoprotein Polyclonal Antibody Usage And Synthesis |
| Description | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped positive-stranded RNA virus, a member of the Betacoronavirus genus, and the causative agent of COVID-19.1,2,3,4,5 The SARS-CoV-2 surface glycoprotein, also known as the spike glycoprotein, is located on the outer envelope of the virion.1 It is composed of an S1 and S2 subunit divided by a furin S-cleavage site not found in other SARS-CoVs.6,7 The S1 subunit contains the receptor-binding domain (RBD), which binds to the carboxypeptidase angiotensin-converting enzyme 2 (ACE2), and the S1 and S2 subunits are cleaved by the protease TMPRSS2 to facilitate viral fusion with the host cell membrane.8,9,10 Cayman’s SARS-CoV-2 Spike Glycoprotein Polyclonal Antibody can be used for ELISA and Western blot (WB) applications. The antibody recognizes the spike glycoprotein from SARS-CoV-2.WARNING This product is not for human or veterinary use. |
| | SARS-CoV-2 Spike Glycoprotein Polyclonal Antibody Preparation Products And Raw materials |
|